Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 462 (CSE: $GTII.C)
(OTCQB: $MGWFF)(CSE: $CURA.C) (NASDAQ: $AMRS)
Delta, Kelowna, BC, September 1, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/090120-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/09011GTII-MGWFF-CURA-AMRS.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on
Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public company announcements.
Green
Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis
consumer packaged goods company and owner of Rise™ and Essence retail stores, today announced that the company has partnered
with Last Prisoner Project (LPP) on an integrated marketing campaign, including
a short documentary, social media advocacy, digital promotions and in-store
programs to raise awareness and funds for LPP’s important work.
LPP is a coalition of cannabis
industry leaders, executives and artists dedicated to bringing restorative
justice to the cannabis industry. The organization’s Clemency and Reentry
Initiatives provide pro-bono post-conviction representation to assist
individuals in securing release and a clean slate to rebuild their lives.
The centerpiece of the campaign is a
short documentary, “Waiting to
Breathe,” created in-house by Green Thumb. The film
highlights the story of Evelyn LaChapelle, a current LPP Advisor who served
more than five years in prison for a cannabis-related offense and has since
rebuilt her life with her young daughter with support from LPP.
Following her release, LaChapelle
was fired from a job when the company learned about her past. “When I got fired
it was like you aren’t done serving your sentence,” said LaChapelle, who
currently works in the legal cannabis industry in California. “It was like this
is never going to go away. It leaves you with an amount of hopelessness.”
Sarah Gersten, Executive Director
and General Counsel of LPP said: “Evelyn’s story really moved all of us and
changed the way we envisioned this project and our mission. All of the barriers
she faced coming out of prison, how difficult it was for her to find
employment, watching her struggle through all of that really gave us the
insight to refocus our efforts, not just on releasing folks from incarceration
but working with them to ensure that they have the resources they need to
successfully reenter.”
According to various sources:
●
An estimated 40,000 people are currently
incarcerated for victimless cannabis offenses. (Source: LPP)
●
92 percent of 663,367 cannabis arrests in
2018 were for possession alone. (Source: FBI Uniform Crime Reporting Program,
2018)
●
Black people are 3.64 times more likely
than white people to be arrested for cannabis possession yet are no more likely
to sell or use cannabis. (Source: ACLU)
A portion of proceeds from Green
Thumb products purchased in the month of September will directly benefit LPP.
Green Thumb Corporate Social
Responsibility Director Michael Fields said: “By partnering with LPP, Green
Thumb hopes to raise awareness of real people like Evelyn whose lives and
families have been positively impacted by LPP, and to provide financial support
to LPP which serves as a vital resource for former cannabis inmates
transitioning to a successful life following incarceration.”
Maple
Leaf Green World Inc. (NEO: MGW) (OTCQB: MGWFF) provided the following update for its
California CBG Hemp Project. A sample from a selective batch of La Crème from
the first 2 greenhouses which is 2 – 4 weeks from full maturity, has been
submitted for lab analysis and the results indicate an incredible 13.90% CBG,
0.07% THC and no other cannabinoids detected. It is noteworthy that most samples
would present traces of other cannabinoids as enzymes break down CBGa to
produce other cannabinoids. The lack of these other cannabinoids indicates a
pure CBG flower.
The plants have been kept longer in
the vegetative stage deliberately to develop larger buds and higher poundage.
The low THC nature of the La Crème strain has allowed the Company to make
adjustments during the vegetative phase to maximize both CBG concentration and
yield. These plants will be ready for harvesting within the next 2 – 4 weeks.
The outdoor crop is also displaying
numerous large buds and is estimated to produce 2 – 3 lbs of flower per plant.
The Company’s cultivation team is excited with the early results and is
confident that the flowers, when fully mature, will achieve a minimum of 18%
CBG. As the Company prepares for its first harvest, clones have also been cut
and setup for the 2nd harvest.
The preliminary Certificate of
Analysis (“COA”) has been posted to the company’s website.
“I am very impressed with the purity
of our first harvest. The low THC nature of this strain gave us the flexibility
to extend the length of our vegetating stage to obtain higher CBG content and
larger buds without the risk of our harvest going hot. This will be resulted in
approximately 30-40% increase in yield. We are excited to see the final results
from a fully mature flower.” said Raymond Lai, Chairman, President & CEO
Curaleaf
Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated
cannabis operator in the United States, today announced that its line of Select Elite
Live cartridges has reached $1 million in sales since launching in the Florida
medical market on August 6.
Select Elite Live features high
quality, high potency oil with a wide variety of strain-specific flavor and
effects. Curaleaf will unveil additional Select product offerings to Florida's
medical patients later this year, including the best-selling high potency broad
spectrum Select Elite cartridges. As a recognized industry leader, Select is
committed to maintaining the highest quality control standards and testing
transparency and delivering the best experience possible.
"We are thrilled to have
received such a positive response to Elite Live from our Florida patients, and
look forward to continuing to provide innovative new products for their
cannabis needs," said Joe Bayern, President of Curaleaf. "The
immediate success of Elite Live in Florida speaks to the power of the Select
brand, and we are confident about our continued growth in the state."
Select, known as America's #1
Cannabis Oil Brand, has been on a path of rapid expansion since it was acquired
by Curaleaf in February 2020. Select products are now available in over 950
independent dispensaries across 12 states, including Arizona, California,
Colorado, Connecticut, Florida, Maryland, Michigan, Nevada, Oklahoma, Oregon,
Massachusetts and Maine. The Select brand will continue to expand across the
U.S. with its launch into Ohio's medical market later this month.
Curaleaf also announced the company's first retail
location in the Utah market with a new pharmacy at 3633 N. Thanksgiving Way in
Lehi, marking its 90th retail location nationwide.
Curaleaf UT, LLC, was awarded one of
the state's 14 licenses in the state of Utah in 2019. Lehi is known as one of
the state's highest growth cities and its surrounding area is home to more than
50% of the state's total qualifying patients; Utah County has 44% of the
certified 10,400 patients.
The new Lehi location is
strategically located directly off the I15, the state's most highly trafficked
freeway, in a high retail density area which will provide optimal patient
access from anywhere in the Utah County area. Curaleaf will be the first
cannabis pharmacy location in the County heading south from Salt Lake on the
I15.
The Company's expansion into Utah
will provide more accessibility to high-quality medical cannabis products,
innovative consumption formats, and leading national brands. Curaleaf is also
completing construction on its state-of-the-art processing operation in North
Salt Lake City, which is scheduled to open in mid-September.
"We look forward to introducing
our Select and Curaleaf formulas to the patients of Utah with our new Lehi
location," said Joe Bayern, President at Curaleaf. "We anticipate
that demand will quickly surpass projected numbers in this market, as cannabis
use continues to gain acceptance for a variety of health and wellness
needs."
During the COVID-19 pandemic,
cannabis businesses have been deemed an essential service in most states,
including Utah. Curaleaf remains committed to serving patients and customers
with the products they rely on while implementing heightened safety and
hygienic measures in all its facilities.
Amyris,
Inc.
(NASDAQ: AMRS), a leading synthetic
biotechnology company in Clean Health and Beauty markets through its consumer
brands, and a top supplier of sustainable and natural ingredients, today announced that it has successfully
scaled up the commercial production of Cannabigerol (CBG) leveraging its
industrial fermentation process capability.
Amyris expects to deliver about one
ton of high purity CBG through fermentation as an alternative to the
traditional production method of extraction from the Cannabis sativa L. plant.
First commercial revenue from the sale of this molecule is anticipated this
year as an ingredient in applications that are excluded from Amyris's current
collaboration agreements. Product margins are anticipated to operate above the
current industry average realized by existing publicly traded CBD suppliers.
CBG is the precursor from which all
other cannabinoids are synthesized and is often referred to as the "stem
cell" of cannabinoids. CBG is a non-psychoactive cannabinoid and presents
significant therapeutic potential, making it a subject of great interest for
researchers and consumers alike. Amyris's fermentation process is well-positioned
to result in the lowest cost CBG with higher purity (no THC), which is expected
to unlock CBG's adoption.
Early testing on skin models
demonstrates advantaged performance of CBG for various topical indications over
CBD. Furthermore, the combination of CBG with Amyris's sugar cane-based
squalene provides some of the highest efficacy results for topical
applications. Early studies indicate that CBG has the potential to deliver
better efficacy than CBD in about one third of current CBD topical
applications.
"Amyris's biotechnology
platform continues to demonstrate its capability to engineer yeast to create
and produce differentiated high value products. This molecule was developed
from initial target to full scale production in less than nine months,"
said Eduardo Alvarez, Chief Operating Officer.
"We are very excited about the
disruptive nature of this molecule for potential skin care applications and
through flavor and fragrance partnerships and our cosmetic distribution
channels," commented John Melo, President and Chief Executive Officer.
"This is the tenth product we deliver at scale through our fermentation
platform, and reaffirms the continued expansion of our portfolio and our growth
ambition to provide sustainably and economically produced natural
ingredients."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
